| http://www.w3.org/ns/prov#value | - Preexisting cardiovascular conditions such as hypertension should be treated before patients receive antiangiogenic agents, and high-risk candidates???such as patients who have previously experienced arterial thromboembolic events???can receive prophylactic treatments such as anticoagulants.Effects in other classes of targeted agentsAlso linked to cardiotoxicity are human epidermal growth factor r
|
